
    
      This is a multi-center, prospective, post-market clinical follow-up study to assess the
      performance and the unknown risks or complications of the Advanced Gynecological Applicator
      (AGA) Venezia configuration during clinical use of the applicator. The AGA Venezia
      configuration is a CE-marked, FDA approved and commercially available product. The AGA
      Venezia configuration is a gynaecological applicator for intracavitary and interstitial
      brachytherapy. The radiation oncologist can use it for treatment of cancers in the vagina,
      cervix and uterus. Forty (40) participants will be included in this study at 5 sites: 3
      centers in Europe and 2 centers in the United States.
    
  